| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 04/19/2022 | 3. Issuer Name and Ticker or Trading Symbol Hayward Holdings, Inc. [ HAYW ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 4,699(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options (Right to Buy) | (2) | 10/29/2031 | Common Stock | 3,243 | 23.19 | D | |
| Stock Options (Right to Buy) | (3) | 03/03/2032 | Common Stock | 12,174 | 17.1 | D | |
| Explanation of Responses: |
| 1. Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The restricted stock units vest as follows: October 29, 2022: 493 restricted stock units; March 3, 2023: 1,072 restricted stock units; October 29, 2023: 494 restricted stock units; March 3, 2024: 1,072 restricted stock units; October 29, 2024: 495 restricted stock units; March 3, 2025: 1,073 restricted stock units; provided generally that the Reporting Person remains in continuous service with the Issuer through the applicable vesting date. |
| 2. This option vests as to the underlying shares of Common Stock in three equal installments, on each of October 29, 2022, October 29, 2023 and October 29, 2024, provided generally that the Reporting Person remains in continuous service with the Issuer through the applicable vesting date. |
| 3. This option vests as to the underlying shares of Common Stock in three equal installments, on each of March 3, 2023, March 3, 2024 and March 3, 2025, provided generally that the Reporting Person remains in continuous service with the Issuer through the applicable vesting date. |
| Remarks: |
| Exhibit 24.1 - Power of Attorney |
| /s/ Susan Canning, attorney-in-fact | 04/29/2022 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
